JLABS | Reducing vein-to-vein time for cell therapy

JLABS | Reducing vein-to-vein time for cell therapy

This Johnson & Johnson–hosted event explores how automation and real-time analytics can speed up the vein-to-vein timeline in CAR-T therapy, with experts sharing advances in manufacturing, quality control, and scalability. The session takes place in Utrecht and is also available online, with the option to combine attendance with the Oncode Accelerator Summit.

Hosted by Johnson & Johnson, this event explores how automation and real-time analytics can shorten the vein-to-vein timeline in CAR-T cell therapy—enhancing access, reducing costs, and improving patient outcomes.

Speakers from Johnson & Johnson, NecstGen, Cellular Origins, SymCel, and NanoCell Tx will share innovations aimed at streamlining manufacturing, quality control, and scalability in cell and gene therapy.

The session will be held in Utrecht (venue to be confirmed) and can also be attended virtually. Participation can be combined with the Oncode Accelerator Summit at Jaarbeurs Utrecht in the afternoon.

Register here

Testimonials

testimonial

Perfect balance of learning and networking.

Smiljka Vikic-Topic

University of Zagreb, Croatia

testimonial

ASTP has attained a unique position that has turned it into a highly valued player on the global technology transfer scene.

Koenraad Debackere

KU Leuven, Belgium

testimonial

Perfect place to meet colleagues and share experiences on Technology Transfer.

Lidia Aguilera

University of Luxembourg, Luxembourg

testimonial

This course offers an opportunity to meet likeminded people, share tips and tricks, and dive into different approaches to help you set up and improve KTO processes.

Brechtje Vreenegoor

Radboud University, Netherlands

testimonial

ASTP Conference offers great networking and learning opportunities;  a chance to share knowledge with colleagues from various areas of expertise.

Bruno Woeran

Merinova OY - TII President, Finland